Achieving undetectable MRD with ibrutinib plus venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 219 Далее Скачать
Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 4 days ago 34 Далее Скачать
MRD-driven addition of ibrutinib to venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:36 3 years ago 115 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
5-year follow-up of patients with CLL treated in first-line with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:13 1 year ago 436 Далее Скачать
ASH CLL highlights: ibrutinib-venetoclax combination & undetectable MRD in IGHV-mutated patients VJHemOnc – Video Journal of Hematology & HemOnc 1:47 2 years ago 536 Далее Скачать
Interim analysis of the FLAIR study: efficacy of ibrutinib plus venetoclax in IgHV unmutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 1 year ago 328 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
AVO achieves high rates of undetectable MRD in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:29 3 years ago 331 Далее Скачать
Exploratory analysis of the CLARITY study: ibrutinib plus venetoclax in patients with R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 173 Далее Скачать
FLAIR trial: improved outcomes with MRD-guided ibrutinib plus venetoclax in CLL compared to FCR VJHemOnc – Video Journal of Hematology & HemOnc 3:00 1 year ago 365 Далее Скачать
MRD outcomes from GLOW: venetoclax and ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:09 3 years ago 188 Далее Скачать
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia ecancer 6:55 3 years ago 377 Далее Скачать
Ibrutinib plus venetoclax for first-line treatment of CLL: 4-year follow-up data VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 485 Далее Скачать
Ibrutinib Plus Venetoclax as a Treatment Option for CLL Targeted Oncology 1:07 5 years ago 822 Далее Скачать
GLOW: Assessing ibrutinib plus venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 364 Далее Скачать
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
Long Term Follow-Up With Ibrutinib + Venetoclax to Treat Chronic Lymphocytic Leukemia CheckRare 5:29 1 year ago 806 Далее Скачать
Ibrutinib + Venetoclax for Chronic Lymphocytic Leukemia (CLL) Treatment - Dr. Bill Wierda ASH 2022 CLL Society 6:39 1 year ago 279 Далее Скачать
CAPTIVATE study: outcomes in patients with uMRD following cessation of ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 107 Далее Скачать
